Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Chemical Society Reviews
|
March 29, 2014
PET/SPECT imaging agents for neurodegenerative diseases
Lin Zhu, Karl Ploessl, Hank F Kung
Nuclear Medicine and Biology
|
November 5, 2013
Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging
Limin Wang, Brian P Lieberman, Karl Ploessl, et al.
Clinical Nuclear Medicine
|
May 23, 2007
Dopamine transporter binding in smokers and nonsmokers
Andrew Newberg, Caryn Lerman, Nancy Wintering, et al.
Tetrahedron Letters
|
January 6, 2009
Synthesis of Fluorescent Probes based on Stilbenes and Diphenylacetylenes targeting β-Amyloid Plaques
Ajit K Parhi, Mei-Ping Kung, Karl Ploessl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 25, 2017
Metabolic Imaging of Glutamine in Cancer
Lin Zhu, Karl Ploessl, Rong Zhou, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 10, 2010
Synthesis and in vitro evaluation of 18F labeled tyrosine derivatives as potential positron emission tomography (PET) imaging agents
Limin Wang, Wenchao Qu, Brian Lieberman, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 27, 2009
Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation
Wenchao Qu, Karl Ploessl, Hong Truong, et al.
Nuclear Medicine and Biology
|
July 17, 2013
Characterization of FlipIDAM as a SERT-selective SPECT imaging agent
Laetitia Lemoine, Brian P Lieberman, Karl Ploessl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 1, 2012
Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents
Karl Ploessl, Limin Wang, Brian P Lieberman, et al.
Nuclear Medicine and Biology
|
March 12, 2018
Alanine and glycine conjugates of (2S,4R)-4-[<sup>18</sup>F]fluoroglutamine for tumor imaging
Zhihao Zha, Karl Ploessl, Brian P Lieberman, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Chemical Society Reviews
|
March 29, 2014
PET/SPECT imaging agents for neurodegenerative diseases
Lin Zhu, Karl Ploessl, Hank F Kung
Nuclear Medicine and Biology
|
November 5, 2013
Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging
Limin Wang, Brian P Lieberman, Karl Ploessl, et al.
Clinical Nuclear Medicine
|
May 23, 2007
Dopamine transporter binding in smokers and nonsmokers
Andrew Newberg, Caryn Lerman, Nancy Wintering, et al.
Tetrahedron Letters
|
January 6, 2009
Synthesis of Fluorescent Probes based on Stilbenes and Diphenylacetylenes targeting β-Amyloid Plaques
Ajit K Parhi, Mei-Ping Kung, Karl Ploessl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 25, 2017
Metabolic Imaging of Glutamine in Cancer
Lin Zhu, Karl Ploessl, Rong Zhou, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 10, 2010
Synthesis and in vitro evaluation of 18F labeled tyrosine derivatives as potential positron emission tomography (PET) imaging agents
Limin Wang, Wenchao Qu, Brian Lieberman, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 27, 2009
Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation
Wenchao Qu, Karl Ploessl, Hong Truong, et al.
Nuclear Medicine and Biology
|
July 17, 2013
Characterization of FlipIDAM as a SERT-selective SPECT imaging agent
Laetitia Lemoine, Brian P Lieberman, Karl Ploessl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 1, 2012
Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents
Karl Ploessl, Limin Wang, Brian P Lieberman, et al.
Nuclear Medicine and Biology
|
March 12, 2018
Alanine and glycine conjugates of (2S,4R)-4-[<sup>18</sup>F]fluoroglutamine for tumor imaging
Zhihao Zha, Karl Ploessl, Brian P Lieberman, et al.
Page
of 6